These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

952 related items for PubMed ID: 12016041

  • 1. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J, Bocciolini C, Fournier C, Penel N, Kara A, Van JT, Lefebvre JL.
    Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
    [Abstract] [Full Text] [Related]

  • 2. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K, Lyden TH, Lee J, Urba SG, Worden F, Eisbruch A, Tsien C, Bradford CR, Chepeha DB, Hogikyan ND, Prince ME, Teknos TN, Wolf GT.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1395-9. PubMed ID: 16087298
    [Abstract] [Full Text] [Related]

  • 3. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M, Mesia R, Mañós M, Gomez J, Galiana R, Cardenal F, Juan A, Montes A, Perez FJ, Nogues J, Llluch JR.
    Laryngoscope; 2006 Sep 01; 116(9):1651-6. PubMed ID: 16954998
    [Abstract] [Full Text] [Related]

  • 4. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
    Zelefsky MJ, Kraus DH, Pfister DG, Raben A, Shah JP, Strong EW, Spiro RH, Bosl GJ, Harrison LB.
    Head Neck; 1996 Sep 01; 18(5):405-11. PubMed ID: 8864731
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation.
    Wolf GT, Fisher SG.
    Laryngoscope; 1992 Aug 01; 102(8):934-9. PubMed ID: 1495357
    [Abstract] [Full Text] [Related]

  • 6. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
    Tian WD, Zeng ZY, Chen FJ, Wu GH, Guo ZM, Zhang Q.
    Ai Zheng; 2006 Jan 01; 25(1):80-4. PubMed ID: 16405756
    [Abstract] [Full Text] [Related]

  • 7. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
    Urba S, Wolf G, Eisbruch A, Worden F, Lee J, Bradford C, Teknos T, Chepeha D, Prince M, Hogikyan N, Taylor J.
    J Clin Oncol; 2006 Feb 01; 24(4):593-8. PubMed ID: 16380415
    [Abstract] [Full Text] [Related]

  • 8. Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: an alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy.
    Lecanu JB, Monceaux G, Périé S, Angelard B, St Guily JL.
    Laryngoscope; 2000 Mar 01; 110(3 Pt 1):412-6. PubMed ID: 10718429
    [Abstract] [Full Text] [Related]

  • 9. Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma.
    Prades JM, Lallemant B, Garrel R, Reyt E, Righini C, Schmitt T, Remini N, Saban-Roche L, Timoshenko AP, Trombert B, Guerrier B.
    Acta Otolaryngol; 2010 Mar 01; 130(1):150-5. PubMed ID: 19449227
    [Abstract] [Full Text] [Related]

  • 10. Function preservation in stage III squamous laryngeal carcinoma: results with an induction chemotherapy protocol.
    de Andrés L, Brunet J, López-Pousa A, Burgués J, Quer M, León X, Guedea F, Vega M, Mesía R, López JJ.
    Laryngoscope; 1995 Aug 01; 105(8 Pt 1):822-6. PubMed ID: 7630294
    [Abstract] [Full Text] [Related]

  • 11. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
    Altundag O, Gullu I, Altundag K, Yalcin S, Ozyar E, Cengiz M, Akyol F, Yucel T, Hosal S, Sozeri B.
    Head Neck; 2005 Jan 01; 27(1):15-21. PubMed ID: 15515158
    [Abstract] [Full Text] [Related]

  • 12. Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx.
    Rivera F, Vega-Villegas ME, López-Brea MF, García-Castaño A, de Juan A, Collado A, Galdós P, Rubio A, del Valle A, Rama J, Sanz-Ortiz J.
    Laryngoscope; 2004 Jul 01; 114(7):1163-9. PubMed ID: 15235341
    [Abstract] [Full Text] [Related]

  • 13. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G, Tsukuda M, Horiuchi C, Satake K, Yoshida T, Nagao J, Kawakami M, Kondo N, Arai Y, Taguchi T, Matsuda H, Mikami Y.
    Auris Nasus Larynx; 2007 Dec 01; 34(4):499-504. PubMed ID: 17604583
    [Abstract] [Full Text] [Related]

  • 14. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer.
    Lee MS, Ho HC, Hsiao SH, Hwang JH, Lee CC, Hung SK.
    Acta Otolaryngol; 2008 Jan 01; 128(1):103-9. PubMed ID: 17851955
    [Abstract] [Full Text] [Related]

  • 15. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M, De Luca MC, Rubino G, Pirtoli L, Pepi F, Sebaste L, Ponticelli P, Atzeni G, Maranzano E, Silvano G.
    Radiol Med; 2001 Jan 01; 102(1-2):72-7. PubMed ID: 11677442
    [Abstract] [Full Text] [Related]

  • 16. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.
    Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J, Faivre S, Guerrif S, Alfonsi M, Calais G.
    J Natl Cancer Inst; 2009 Apr 01; 101(7):498-506. PubMed ID: 19318632
    [Abstract] [Full Text] [Related]

  • 17. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS, Chung WK, Ahn SJ, Nam TK, Nah BS, Song JY, Lim SC, Lee JK.
    Acta Otolaryngol; 2008 May 01; 128(5):590-6. PubMed ID: 18421617
    [Abstract] [Full Text] [Related]

  • 18. Searching for less toxic larynx preservation: a need for common definitions and metrics.
    Forastiere AA, Trotti AM.
    J Natl Cancer Inst; 2009 Feb 04; 101(3):129-31. PubMed ID: 19176460
    [No Abstract] [Full Text] [Related]

  • 19. High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx.
    Lacava JA, Ferreyra R, Leone BA, Losada C, Elem YL, Vallejo CT.
    Cancer J Sci Am; 1996 Feb 04; 2(1):46-51. PubMed ID: 9166498
    [Abstract] [Full Text] [Related]

  • 20. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J.
    Arch Otolaryngol Head Neck Surg; 2004 Jul 04; 130(7):861-7. PubMed ID: 15262764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.